Introduction: In general practice, COPD is often under-diagnosed and inappropriate pharmacological treatment given.
Objectives: To determine the profile of patients over 40 years old, smokers or ex-smokers, referred by general practitioners to respiratory physicians for assessment of undiagnosed bronchial disease.
Methods: Observational study carried-out among 103 respiratory physicians in France in 2007.
Results: The diagnosis of COPD was confirmed by the respiratory physicians in 433/486 (89%) patients. COPD patients were aged 61 years on average, male (63%) and often current smokers (46%). Most of them had more than three respiratory symptoms. The diagnosis of COPD was made after a long history of symptoms. We found 148 (34.2%) COPD patients with a FEV(1)/FVC greater than 0.7 and were classified as mild (61 patients), moderate (77 patients) or severe (10 patients).
Conclusions: In patients at risk, smokers or ex-smokers with respiratory symptoms, COPD was the diagnosis most often confirmed by the respiratory physician. A significant proportion of respiratory physicians diagnosed and assessed the severity of COPD, not strictly on the basis of national recommendations, but rather on the association of risk factors, respiratory symptoms and even isolated changes in FEV(1).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rmr.2010.03.007 | DOI Listing |
Eur Clin Respir J
January 2025
Department of Clinical Medicine, Aarhus University & Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Diagnosis of subglottic stenosis remains greatly a challenge for physicians due to case rarity and presentation of symptoms imitating several other more prevalent medical disorders. Idiopathic subglottic stenosis most often occurs in previously healthy perimenopausal Caucasian women. Several cases have reported symptom progression and increased stenosis, during or in between pregnancies in younger women.
View Article and Find Full Text PDFBMC Med Inform Decis Mak
January 2025
NHC Key Laboratory of Pneumoconiosis, Taiyuan, China.
Background: Many respiratory diseases such as pneumoconiosis require to close monitor the symptoms such as abnormal respiration and cough. This study introduces an automated, nonintrusive method for detecting cough events in clinical settings using a flexible chest patch with tri-axial acceleration sensors.
Methods: Twenty-five young healthy persons (hereinafter referred to as healthy adults) and twenty-five clinically diagnosed pneumoconiosis patients (hereinafter referred to as patients) participated in the experiment by wearing a flexible chest patch with an embedded ACC sensor.
BMJ Open
January 2025
Department of Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University; Guangxi Clinical Research Center for Critical Care Medicine, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
Objectives: This study aimed to assess the knowledge, attitudes and practices (KAP) of intensive care unit (ICU) physicians in China towards acute respiratory distress syndrome (ARDS).
Design: A cross-sectional study was conducted between September and November 2022.
Participants: A total of 497 ICU physicians participated, with 258 (51.
Braz J Anesthesiol
January 2025
Hospital de Clínicas de Porto Alegre, Serviço de Pneumologia, Programa de Residência Médica em Medicina do Sono e Suporte Ventilatório, Porto Alegre, RS, Brazil.
Growing evidence of the benefits of home ventilatory support in patients with chronic respiratory failure along with technological advances in ventilators have enabled their use in overly complex situations, shaping a new scenario for physicians. This has further given rise to new challenges related to their incorporation into current medical practice. However, this evolution needs to be coupled with knowledge and skills of physicians who are willing to prescribe Home Mechanical Ventilation (HMV), in order to prevent them from making inappropriate choices or adjustments that may ultimately have ethical and legal implications.
View Article and Find Full Text PDFAntiviral Res
January 2025
CIRI, Centre International de Recherche en Infectiologie, INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon, 21 Avenue Tony Garnier, 69007 Lyon, France.
Nipah virus (NiV) is a lethal zoonotic paramyxovirus that can be transmitted from person to person through the respiratory route. There are currently no licensed vaccines or therapeutics. A lipopeptide-based fusion inhibitor was developed and previously evaluated for efficacy against the NiV-Malaysia strain.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!